- Home
- FMST vs PLSM Comparison
FMST vs PLSM Comparison
Compare FMST & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FMST | PLSM |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 11.6M |
| IPO Year | 2022 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FMST | PLSM |
|---|---|---|
| Price | $0.68 | $1.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 268.9K | 15.7K |
| Earning Date | 11-24-2026 | 08-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.42 | $1.42 |
| 52 Week High | $3.49 | $12.97 |
Technical Indicators
Market Signals| Indicator | FMST | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 51.99 | 31.04 |
| Support Level | $0.45 | $1.42 |
| Resistance Level | $0.70 | $2.64 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 43.81 | 8.85 |
Price Performance
Historical ComparisonAbout FMST Foremost Lithium Resource & Technology Ltd.
Foremost Clean Energy Ltd is an exploration company focused on the identification and development of high potential mineral opportunities in stable jurisdictions. Its Uranium properties includes Eastern Athabasca, and Blue-Sky. Its Lithium properties includes Zoro Lithium Project, JEAN LAKE LITHIUM GOLD PROJECT, Peg North Project, Grass River Claims Project, and JOL LITHIUM PROJECT.
About PLSM Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.